Asset Details
Do you wish to reserve the book?
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology
Do you wish to request the book?
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology
2014
Overview
In 2010, the International Society of Geriatric Oncology (SIOG) developed treatment guidelines for men with prostate cancer who are older than 70 years old. In 2013, a new multidisciplinary SIOG working group was formed to update these recommendations. The consensus of the task force is that older men with prostate cancer should be managed according to their individual health status, not according to age. On the basis of a validated rapid health status screening instrument and simple assessment, the task force recommends that patients are classed into three groups for treatment: healthy or fit patients who should have the same treatment options as younger patients; vulnerable patients with reversible impairment who should receive standard treatment after medical intervention; and frail patients with non-reversible impairment who should receive adapted treatment.
Publisher
Elsevier Ltd,Elsevier Limited
Subject
/ Aged
/ Androgen Antagonists - therapeutic use
/ Antineoplastic Agents, Hormonal - therapeutic use
/ Health Services for the Aged - standards
/ Hematology, Oncology and Palliative Medicine
/ Humans
/ Male
/ Men
/ Practice Guidelines as Topic
/ Prostatic Neoplasms - mortality
/ Prostatic Neoplasms - pathology
/ Prostatic Neoplasms - therapy
/ Radiotherapy, Conformal - methods
